Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.76 |
| ▸ | MIF | P14174 | 1/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.75 |
| ▸ | HPGD | P15428 | 7/20 | 0.75 |
| ▸ | MAPT | P10636 | 6/20 | 0.75 |
| ▸ | NPC1 | O15118 | 5/20 | 0.75 |
| ▸ | RAB9A | P51151 | 5/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.75 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.75 |
| ▸ | TP53 | P04637 | 3/20 | 0.75 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.75 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.75 |
| ▸ | MAOA | P21397 | 2/20 | 0.75 |
| ▸ | MAOB | P27338 | 2/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.75 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.75 |
| ▸ | BLM | P54132 | 2/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29929481 | 1.00 | XDH (0.76) | XDHMIFKDM4EALDH1A1HSD17B10 | |
| SCHEMBL13904607 | 0.88 | KDM4E (0.79) | XDHMIFKDM4EALDH1A1HSD17B10 | |
| SCHEMBL29392289 | 0.87 | XDH (1.00) | XDHMIFKDM4EALDH1A1HSD17B10 | |
| SCHEMBL73012 | 0.87 | XDH (1.00) | XDHMIFKDM4EALDH1A1HSD17B10 | |
| SCHEMBL29482679 | 0.87 | XDH (1.00) | XDHMIFKDM4EALDH1A1HSD17B10 | |
| SCHEMBL29482686 | 0.87 | XDH (1.00) | XDHMIFKDM4EALDH1A1HSD17B10 | |
| Daidzein SCHEMBL21114371 | 0.86 | KDM4E (1.00) | XDHMIFKDM4EALDH1A1HSD17B10 | |
| Daidzein SCHEMBL29374778 | 0.86 | KDM4E (1.00) | XDHMIFKDM4EALDH1A1HSD17B10 | |
| Daidzein SCHEMBL19814 | 0.86 | KDM4E (1.00) | XDHMIFKDM4EALDH1A1HSD17B10 | |
| SCHEMBL13904558 | 0.85 | KDM4E (0.72) | XDHMIFKDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| EP-1808169-B1 | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases | PROTEOTECH INC (US) | 2012-05-30 | — | — | EP | claimed |
| US-8163806-B2 | Controlled release of biologically active compounds from multi-armed oligomers | BEZWADA BIOMEDICAL, LLC (US) | 2012-04-24 | — | — | US | claimed |
| US-20120010284-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | BEZWADA BIOMEDICAL, LLC (US) | 2012-01-12 | — | — | US | claimed |
| EP-0582623-A1 | HIGH-TEMPERATURE ADHESIVE COMPOSITIONS | LORD CORPORATION (US) | 1994-02-16 | — | — | EP | claimed |
| CN-1078984-A | The acrylonitrile butadiene copolymer rubber adhesive | LORD CORP (US) | 1993-12-01 | — | — | CN | claimed |
| WO-1993022390-A1 | ACRYLONITRILE-BUTADIENE COPOLYMER RUBBER ADHESIVE | LORD CORPORATION (US) | 1993-11-11 | — | — | WO | claimed |
| US-5162156-A | PHENOLIC RESIN ADHESION PROMOTERS AND ADHESIVE COMPOSITIONS, AND BONDING METHOD EMPLOYING SAME | LORD CORPORATION (US) | 1992-11-10 | — | — | US | claimed |
| WO-1992018566-A1 | HIGH-TEMPERATURE ADHESIVE COMPOSITIONS | LORD CORPORATION (US) | 1992-10-29 | — | — | WO | claimed |
| CN-1065672-A | The high-temperature adhesives composition | LORD CORP (US) | 1992-10-28 | — | — | CN | claimed |
| EP-0508650-A2 | High-temperature adhesive compositions | LORD CORPORATION (US) | 1992-10-14 | — | — | EP | claimed |
| US-5128403-A | A mixture of perhalocyclic diene-modified polyconjugated diene, phenolic resin, a phenol, an aldehyde, thermosensitive elastomer crosslinker, vulcanizer and metal oxide; bonding metal and elastomer; heat resistance | LORD CORPORATION (US) | 1992-07-07 | — | — | US | claimed |
| CN-1060101-A | Phenolic resin adhesion promoters and binder composition | LORD CORP (US) | 1992-04-08 | — | — | CN | claimed |
| EP-0476902-A2 | Phenolic resin adhesion promoters and adhesive compositions | LORD CORPORATION (US) | 1992-03-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | XDH 3154/4885MIF 265/4885KDM4E 4637/4885 |
| US-20120010284-A1 | CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | MME, AADAC, LGMN | XDH 3893/4885MIF 550/4885KDM4E 4077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.